228 filings
Page 6 of 12
S-4/A
GRI
GRI Bio Inc
Registration of securities issued in business combination transactions (amended)
24 Feb 23
6:05am
CORRESP
GRI
GRI Bio Inc
24 Feb 23
Correspondence with SEC
12:00am
10-K
2022 FY
GRI
GRI Bio Inc
Annual report
23 Feb 23
9:58pm
UPLOAD
GRI
GRI Bio Inc
14 Feb 23
Letter from SEC
12:00am
SC 13G/A
GRI
GRI Bio Inc
13 Feb 23
Vallon Pharmaceuticals / Lind Global Fund II ownership change
4:30pm
S-4/A
GRI
GRI Bio Inc
Registration of securities issued in business combination transactions (amended)
9 Feb 23
5:22pm
CORRESP
GRI
GRI Bio Inc
9 Feb 23
Correspondence with SEC
12:00am
UPLOAD
GRI
GRI Bio Inc
8 Feb 23
Letter from SEC
12:00am
SC 13G/A
Bigger Capital Fund L P
30 Jan 23
Vallon Pharmaceuticals / BIGGER CAPITAL FUND L P ownership change
9:09am
S-4/A
GRI
GRI Bio Inc
27 Jan 23
Registration of securities issued in business combination transactions (amended)
6:02pm
CORRESP
GRI
GRI Bio Inc
27 Jan 23
Correspondence with SEC
12:00am
UPLOAD
GRI
GRI Bio Inc
19 Jan 23
Letter from SEC
12:00am
425
GRI
GRI Bio Inc
11 Jan 23
Business combination disclosure
8:30am
8-K
GRI
GRI Bio Inc
11 Jan 23
Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event
8:30am
8-K
GRI
GRI Bio Inc
29 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
SC 13G/A
Markey John
27 Dec 22
Vallon Pharmaceuticals / Markey John ownership change
11:09am
S-4
GRI
GRI Bio Inc
23 Dec 22
Registration of securities issued in business combination transactions
6:06am
4
Marella Thorell
15 Dec 22
Vallon Pharmaceuticals / Marella Thorell ownership change
4:26pm
8-K
GRI
GRI Bio Inc
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
10-Q
2022 Q3
GRI
GRI Bio Inc
Quarterly report
3 Nov 22
4:34pm